(19)
(11) EP 3 234 106 A1

(12)

(43) Date of publication:
25.10.2017 Bulletin 2017/43

(21) Application number: 15871241.4

(22) Date of filing: 18.12.2015
(51) International Patent Classification (IPC): 
C12N 1/21(2006.01)
C07K 14/025(2006.01)
C07K 14/47(2006.01)
A61K 39/02(2006.01)
A61K 39/39(2006.01)
C12N 15/31(2006.01)
C07K 14/195(2006.01)
C07K 16/28(2006.01)
A61K 39/12(2006.01)
A61K 39/395(2006.01)
(86) International application number:
PCT/US2015/066896
(87) International publication number:
WO 2016/100929 (23.06.2016 Gazette 2016/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 19.12.2014 US 201462094472 P
19.12.2014 US 201462094349 P
14.04.2015 US 201562147463 P
03.12.2015 US 201562262896 P

(71) Applicants:
  • Advaxis, Inc.
    Princeton, NJ 08540 (US)
  • Augusta University Research Institute, Inc.
    Augusta, GA 30912 (US)

(72) Inventors:
  • KHLEIF, Samir
    Silver Springs, Maryland 20906 (US)
  • MKRTICHYAN, Mikayel
    Millbrae, CA 94030 (US)
  • PETIT, Robert
    Newtown, PA 18940 (US)
  • WALLECHA, Anu
    Yardley, PA 19067 (US)

(74) Representative: J A Kemp 
14 South Square Gray's Inn
London WC1R 5JJ
London WC1R 5JJ (GB)

   


(54) COMBINATION OF LISTERIA-BASED VACCINE WITH ANTI-OX40 OR ANTI-GITR ANTIBODIES